Skip to main content

Aarti Drugs gains 6% as board to consider buyback on March 19

In the past six months, the stock of Aarti Drugs has underperformed the market by falling 7 per cent as against a 29 per cent rally in the Sensex

from Home Page https://ift.tt/3cF9TOS

Comments

Popular posts from this blog